Search
EyePoint Pharmaceuticals Inc
EYPTAdd to Watchlist
13.580USD
+0.430+3.27%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.13BMarket Cap
LossP/E TTM
EyePoint Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of EyePoint Pharmaceuticals Inc is 6.48, ranking 149 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -3.87, which is -78.52% below the recent high of -0.83 and -321.43% above the recent low of -16.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
